Global outGRID will centralize Alzheimer’s research online

Wednesday, February 22, 2012 01:56 PM

Europe’s neuGRID, a cloud-computing infrastructure that stores and analyses a vast database of 3D brain scans, is joining with Canada’s CBRAIN and the U.S.’s LONI to create outGRID, a global online system to centralize and boost Alzheimer’s research initiatives.

The convergence of e-infrastructures will be supported by the United Nations’ International Telecommunication Union (ITU) and will allow scientists worldwide to share their medical data while accessing the extensive information available online, thus helping them to draw more precise conclusions about the onset and development of Alzheimer’s.

“outGRID will allow for fully exploiting research efforts developed around the world, which are currently fragmented and often duplicated,” said Dr. Giovanni Frisoni, neuGRID and outGRID coordinator. “Most countries are devoting resources to neuroimaging studies on earlier Alzheimer’s diagnosis and the development of disease markers to be used in clinical drug trials, but a lack of coordination between these initiatives limits the prospect of making substantial scientific advancements.”

Kostas Glinos, head of e-infrastructure at the European Commission’s Directorate General for Information Society, added, “With the strong commitment of research centers and support of public funds, outGRID should succeed in establishing a global infrastructure that maximizes the use of MRIs and accelerates progress in combating Alzheimer’s.”

This new partnership takes outGRID one step closer to its goal of reaching full interoperability between scientific research centers worldwide, facilitating earlier diagnosis of Alzheimer’s.

Share:          
CWWeekly

May 21

Parexel consultant testifies on FDA biosimilars guidance

Global Telecom Testing checks ex-U.S. toll-free phone lines for multinational clinical trials

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

May

Newer sites most optimistic about the future
Investigative sites of all sizes, from part-time physician-run sites to large dedicated research centers, report a rebound in operating conditions, according to a new CenterWatch analysis, yet sites from each subgroup indicate they have concerns…

Risk-based monitoring slow to catch on with industry
It's estimated that the cost of physically sending monitors to all investigative sites at regular intervals, a model the industry itself developed and has adhered to for about a decade, eats up one-third to one-half of…

Eye On Millennium
Millennium, The Takeda Oncology Company, discovers and develops novel treatments applying world-class recombinant technology to a wide variety of oncology disease targets…

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs